189 related articles for article (PubMed ID: 20516456)
1. Molecular staging of intracranial ependymoma in children and adults.
Korshunov A; Witt H; Hielscher T; Benner A; Remke M; Ryzhova M; Milde T; Bender S; Wittmann A; Schöttler A; Kulozik AE; Witt O; von Deimling A; Lichter P; Pfister S
J Clin Oncol; 2010 Jul; 28(19):3182-90. PubMed ID: 20516456
[TBL] [Abstract][Full Text] [Related]
2. Chromosomal abnormalities subdivide ependymal tumors into clinically relevant groups.
Hirose Y; Aldape K; Bollen A; James CD; Brat D; Lamborn K; Berger M; Feuerstein BG
Am J Pathol; 2001 Mar; 158(3):1137-43. PubMed ID: 11238062
[TBL] [Abstract][Full Text] [Related]
3. Optimizing biomarkers for accurate ependymoma diagnosis, prognostication, and stratification within International Clinical Trials: A BIOMECA study.
Chapman RJ; Ghasemi DR; Andreiuolo F; Zschernack V; Espariat AT; Buttarelli FR; Giangaspero F; Grill J; Haberler C; Paine SML; Scott I; Jacques TS; Sill M; Pfister S; Kilday JP; Leblond P; Massimino M; Witt H; Modena P; Varlet P; Pietsch T; Grundy RG; Pajtler KW; Ritzmann TA
Neuro Oncol; 2023 Oct; 25(10):1871-1882. PubMed ID: 36916248
[TBL] [Abstract][Full Text] [Related]
4. Pediatric spinal ependymoma with chromothripsis of chromosome 6: a case report and review of the literature.
Scott KR; Gener MA; Repnikova EA
J Med Case Rep; 2024 Feb; 18(1):95. PubMed ID: 38351155
[TBL] [Abstract][Full Text] [Related]
5. The current consensus on the clinical management of intracranial ependymoma and its distinct molecular variants.
Pajtler KW; Mack SC; Ramaswamy V; Smith CA; Witt H; Smith A; Hansford JR; von Hoff K; Wright KD; Hwang E; Frappaz D; Kanemura Y; Massimino M; Faure-Conter C; Modena P; Tabori U; Warren KE; Holland EC; Ichimura K; Giangaspero F; Castel D; von Deimling A; Kool M; Dirks PB; Grundy RG; Foreman NK; Gajjar A; Korshunov A; Finlay J; Gilbertson RJ; Ellison DW; Aldape KD; Merchant TE; Bouffet E; Pfister SM; Taylor MD
Acta Neuropathol; 2017 Jan; 133(1):5-12. PubMed ID: 27858204
[TBL] [Abstract][Full Text] [Related]
6. Integrating Tenascin-C protein expression and 1q25 copy number status in pediatric intracranial ependymoma prognostication: A new model for risk stratification.
Andreiuolo F; Le Teuff G; Bayar MA; Kilday JP; Pietsch T; von Bueren AO; Witt H; Korshunov A; Modena P; Pfister SM; Pagès M; Castel D; Giangaspero F; Chimelli L; Varlet P; Rutkowski S; Frappaz D; Massimino M; Grundy R; Grill J;
PLoS One; 2017; 12(6):e0178351. PubMed ID: 28617804
[TBL] [Abstract][Full Text] [Related]
7. Significant increase of high-risk chromosome 1q gain and 6q loss at recurrence in posterior fossa group A ependymoma: A multicenter study.
Donson AM; Bertrand KC; Riemondy KA; Gao D; Zhuang Y; Sanford B; Norris GA; Chapman RJ; Fu R; Willard N; Griesinger AM; Ribeiro de Sousa G; Amani V; Grimaldo E; Hankinson TC; Booker F; Sill M; Grundy RG; Pajtler KW; Ellison DW; Foreman NK; Ritzmann TA
Neuro Oncol; 2023 Oct; 25(10):1854-1867. PubMed ID: 37246777
[TBL] [Abstract][Full Text] [Related]
8. Chromosomal anomalies and prognostic markers for intracranial and spinal ependymomas.
Yang I; Nagasawa DT; Kim W; Spasic M; Trang A; Lu DC; Martin NA
J Clin Neurosci; 2012 Jun; 19(6):779-85. PubMed ID: 22516549
[TBL] [Abstract][Full Text] [Related]
9. Emerging insights into the ependymoma epigenome.
Mack SC; Witt H; Wang X; Milde T; Yao Y; Bertrand KC; Korshunov A; Pfister SM; Taylor MD
Brain Pathol; 2013 Mar; 23(2):206-9. PubMed ID: 23432646
[TBL] [Abstract][Full Text] [Related]
10. Clinically relevant molecular hallmarks of PFA ependymomas display intratumoral heterogeneity and correlate with tumor morphology.
Gödicke S; Kresbach C; Ehlert M; Obrecht D; Altendorf L; Hack K; von Hoff K; Carén H; Melcher V; Kerl K; Englinger B; Filbin M; Pajtler KW; Gojo J; Pietsch T; Rutkowski S; Schüller U
Acta Neuropathol; 2024 Jan; 147(1):23. PubMed ID: 38265527
[TBL] [Abstract][Full Text] [Related]
11. Development of Chromosome 1q+ Specific Treatment for Highest Risk Pediatric Posterior Fossa Ependymoma.
Griesinger AM; Calzadilla AJ; Grimaldo E; Donson AM; Amani V; Pierce AM; Steiner J; Kargar S; Serkova NJ; Bertrand KC; Wright KD; Vibhakar R; Hankinson T; Handler M; Lindsay HB; Foreman NK; Dorris K
Clin Cancer Res; 2024 Apr; 30(8):1544-1554. PubMed ID: 38334950
[TBL] [Abstract][Full Text] [Related]
12. 3D genome mapping identifies subgroup-specific chromosome conformations and tumor-dependency genes in ependymoma.
Okonechnikov K; Camgöz A; Chapman O; Wani S; Park DE; Hübner JM; Chakraborty A; Pagadala M; Bump R; Chandran S; Kraft K; Acuna-Hidalgo R; Reid D; Sikkink K; Mauermann M; Juarez EF; Jenseit A; Robinson JT; Pajtler KW; Milde T; Jäger N; Fiesel P; Morgan L; Sridhar S; Coufal NG; Levy M; Malicki D; Hobbs C; Kingsmore S; Nahas S; Snuderl M; Crawford J; Wechsler-Reya RJ; Davidson TB; Cotter J; Michaiel G; Fleischhack G; Mundlos S; Schmitt A; Carter H; Michealraj KA; Kumar SA; Taylor MD; Rich J; Buchholz F; Mesirov JP; Pfister SM; Ay F; Dixon JR; Kool M; Chavez L
Nat Commun; 2023 Apr; 14(1):2300. PubMed ID: 37085539
[TBL] [Abstract][Full Text] [Related]
13. Delineation of two clinically and molecularly distinct subgroups of posterior fossa ependymoma.
Witt H; Mack SC; Ryzhova M; Bender S; Sill M; Isserlin R; Benner A; Hielscher T; Milde T; Remke M; Jones DT; Northcott PA; Garzia L; Bertrand KC; Wittmann A; Yao Y; Roberts SS; Massimi L; Van Meter T; Weiss WA; Gupta N; Grajkowska W; Lach B; Cho YJ; von Deimling A; Kulozik AE; Witt O; Bader GD; Hawkins CE; Tabori U; Guha A; Rutka JT; Lichter P; Korshunov A; Taylor MD; Pfister SM
Cancer Cell; 2011 Aug; 20(2):143-57. PubMed ID: 21840481
[TBL] [Abstract][Full Text] [Related]
14. Molecular Classification of Ependymal Tumors across All CNS Compartments, Histopathological Grades, and Age Groups.
Pajtler KW; Witt H; Sill M; Jones DT; Hovestadt V; Kratochwil F; Wani K; Tatevossian R; Punchihewa C; Johann P; Reimand J; Warnatz HJ; Ryzhova M; Mack S; Ramaswamy V; Capper D; Schweizer L; Sieber L; Wittmann A; Huang Z; van Sluis P; Volckmann R; Koster J; Versteeg R; Fults D; Toledano H; Avigad S; Hoffman LM; Donson AM; Foreman N; Hewer E; Zitterbart K; Gilbert M; Armstrong TS; Gupta N; Allen JC; Karajannis MA; Zagzag D; Hasselblatt M; Kulozik AE; Witt O; Collins VP; von Hoff K; Rutkowski S; Pietsch T; Bader G; Yaspo ML; von Deimling A; Lichter P; Taylor MD; Gilbertson R; Ellison DW; Aldape K; Korshunov A; Kool M; Pfister SM
Cancer Cell; 2015 May; 27(5):728-43. PubMed ID: 25965575
[TBL] [Abstract][Full Text] [Related]
15. C11orf95-RELA fusions drive oncogenic NF-κB signalling in ependymoma.
Parker M; Mohankumar KM; Punchihewa C; Weinlich R; Dalton JD; Li Y; Lee R; Tatevossian RG; Phoenix TN; Thiruvenkatam R; White E; Tang B; Orisme W; Gupta K; Rusch M; Chen X; Li Y; Nagahawhatte P; Hedlund E; Finkelstein D; Wu G; Shurtleff S; Easton J; Boggs K; Yergeau D; Vadodaria B; Mulder HL; Becksfort J; Gupta P; Huether R; Ma J; Song G; Gajjar A; Merchant T; Boop F; Smith AA; Ding L; Lu C; Ochoa K; Zhao D; Fulton RS; Fulton LL; Mardis ER; Wilson RK; Downing JR; Green DR; Zhang J; Ellison DW; Gilbertson RJ
Nature; 2014 Feb; 506(7489):451-5. PubMed ID: 24553141
[TBL] [Abstract][Full Text] [Related]
16. Distinct disease-risk groups in pediatric supratentorial and posterior fossa ependymomas.
Godfraind C; Kaczmarska JM; Kocak M; Dalton J; Wright KD; Sanford RA; Boop FA; Gajjar A; Merchant TE; Ellison DW
Acta Neuropathol; 2012 Aug; 124(2):247-57. PubMed ID: 22526017
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical analysis of H3K27me3 demonstrates global reduction in group-A childhood posterior fossa ependymoma and is a powerful predictor of outcome.
Panwalkar P; Clark J; Ramaswamy V; Hawes D; Yang F; Dunham C; Yip S; Hukin J; Sun Y; Schipper MJ; Chavez L; Margol A; Pekmezci M; Chung C; Banda A; Bayliss JM; Curry SJ; Santi M; Rodriguez FJ; Snuderl M; Karajannis MA; Saratsis AM; Horbinski CM; Carret AS; Wilson B; Johnston D; Lafay-Cousin L; Zelcer S; Eisenstat D; Silva M; Scheinemann K; Jabado N; McNeely PD; Kool M; Pfister SM; Taylor MD; Hawkins C; Korshunov A; Judkins AR; Venneti S
Acta Neuropathol; 2017 Nov; 134(5):705-714. PubMed ID: 28733933
[TBL] [Abstract][Full Text] [Related]
18. Molecular predictive and prognostic factors in ependymoma.
Benson R; Mallick S; Julka PK; Rath GK
Neurol India; 2016; 64(2):279-86. PubMed ID: 26954807
[TBL] [Abstract][Full Text] [Related]
19. Molecular genetics of ependymomas and pediatric diffuse gliomas: a short review.
Nobusawa S; Hirato J; Yokoo H
Brain Tumor Pathol; 2014 Oct; 31(4):229-33. PubMed ID: 25182241
[TBL] [Abstract][Full Text] [Related]
20. Cross-species genomics matches driver mutations and cell compartments to model ependymoma.
Johnson RA; Wright KD; Poppleton H; Mohankumar KM; Finkelstein D; Pounds SB; Rand V; Leary SE; White E; Eden C; Hogg T; Northcott P; Mack S; Neale G; Wang YD; Coyle B; Atkinson J; DeWire M; Kranenburg TA; Gillespie Y; Allen JC; Merchant T; Boop FA; Sanford RA; Gajjar A; Ellison DW; Taylor MD; Grundy RG; Gilbertson RJ
Nature; 2010 Jul; 466(7306):632-6. PubMed ID: 20639864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]